FIELD: organic chemistry, peptides. SUBSTANCE: product: cyclopeptides of the formula (I): where: R1 - hydrogen or acyl; R2 - hydroxy- or acylhydroxy-group; R3 - hydroxysulfonyloxy-group; R4 - carbamoyl at condition that R1 can not be palmitoyl when R2 - hydroxy and R3 - hydroxysulfonyloxy-group, or their pharmaceutical salts; methods of their synthesis: (a) by R1-group splitting off; (b) synthesis of compound of the formula (I) where R1 - acyl by (I) acylation where R1 - H; (c) by synthesis of (I) where R1 - ap-(lower)-alkanoyl by amino-groups deblocking and d) synthesis of compounds of the formula (I) where R1 - pyridyl-thio-(lower)-alkanoyl by interaction of (I) where R1 - halogen-(lower)-alkanoyl with pyridine-thione; (e) synthesis of (I) where Rl - acyloxy by acylation of (I) where R2 - hydroxy-group; pharmaceutical composition showing antimicrobial activity and containing (I) as an active component taken at effective amount. Synthesized compounds are used in medicine. EFFECT: improved method of synthesis. 8 cl, 4 tbl
Title |
Year |
Author |
Number |
PYRAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1993 |
- Masaaki Matsuo
- Kijosi Tsudzi
- Takasi Ogino
- Nobukijo Konisi
|
RU2128172C1 |
PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF TACHYKININ EFFECT |
1993 |
- Masaaki Matsuo
- Dajdzhiro Khagivara
- Khirosi Mijake
|
RU2119922C1 |
CEPHEM COMPOUNDS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1992 |
- Kazuo Sakane[Jp]
- Kokhdzi Kavabata[Jp]
- Kenzi Mijaj[Jp]
- Esikhiko Inamoto[Jp]
|
RU2081874C1 |
DERIVATIVES OF INDOLYLPYPERIDINE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1991 |
- Masaaki Matsuo[Jp]
- Takasi Manabe[Jp]
- Sindzi Sigenaga[Jp]
- Khirosi Masuda[Jp]
|
RU2039056C1 |
PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF PROPHYLAXIS AND ELIMINATION OF THROMBOSIS |
1992 |
- Khisasi Takasuki[Jp]
- Akito Tanaka[Jp]
- Khiroesi Sakai[Jp]
- Takatosi Isikava[Jp]
|
RU2103276C1 |
ETHANOLAMINE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT |
1993 |
- Juiti Siokava
- Masanobu Nagano
- Kijosi Taniguti
- Kazukhiko Take
- Takesi Kato
- Kazunori Tsubaki
|
RU2125983C1 |
METHOD OF SYNTHESIS OF PYRAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1990 |
- Matsuo Masaaki[Jp]
- Tsudzi Kiesi[Jp]
- Konisi Nobukie[Jp]
- Nakamura Katsuja[Jp]
|
RU2021990C1 |
POLYPEPTIDE COMPOUNDS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF PROPHYLAXIS AND/OR THERAPEUTIC TREATMENT |
1994 |
- Khidenori Okhki
- Masaki Tomisima
- Akira Jamada
- Khisasi Takasugi
|
RU2164230C2 |
METHOD OF SYNTHESIS OF ALKANESULFONANILIDE DERIVATIVES OR THEIRS PHARMACEUTICALLY ACCEPTABLE SALTS |
1988 |
- Masaaki Matsuo[Jp]
- Kiesi Tsudzi[Jp]
- Nobukie Konisi[Jp]
- Khirojuki Okumura[Jp]
|
RU2012557C1 |
HETEROCYCLIC COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND INTERMEDIATE COMPOUNDS |
1994 |
- Taniguti Kiesi
- Nagano Masanobu
- Khattori Kojudzi
- Tsubaki Kazunori
- Okitsu Osamu
- Tabuti Sejitiro
|
RU2176640C2 |